Found: 9
Select item for more details and to access through your institution.
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The LIN28B–let‐7–PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1784, doi. 10.1002/1878-0261.13477
- By:
- Publication type:
- Article
Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01848-2
- By:
- Publication type:
- Article
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01684-w
- By:
- Publication type:
- Article
TCF12 is mutated in anaplastic oligodendroglioma.
- Published in:
- Nature Communications, 2015, v. 6, n. 6, p. 7207, doi. 10.1038/ncomms8207
- By:
- Publication type:
- Article
ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
- Published in:
- Nucleic Acids Research, 2021, v. 49, n. 9, p. 5038, doi. 10.1093/nar/gkab305
- By:
- Publication type:
- Article
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03654-9
- By:
- Publication type:
- Article
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17357-4
- By:
- Publication type:
- Article
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13657-6
- By:
- Publication type:
- Article